New project to shed light on neuropsychiatric disorder NEW YORK, NY (September 19, 2023) – The New York Genome Center (NYGC) is excited to announce it has received a 3-year grant of $4.5M from BD²: Breakthrough Discoveries for Thriving with Bipolar Disorder to support research aimed at better understanding the biological processes underlying bipolar disorder […]
NEW YORK, NY (April 5, 2023) — The New York Genome Center (NYGC), The Broad Institute of MIT and Harvard, and The University of California, Los Angeles (UCLA), will collaborate to create the BD2 Genetics Platform. This collaborative effort will perform genetic sequencing on one of the largest and most diverse populations of people with […]
